Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jason Duncan currently holds 750,000 shares of ALBIREO PHARMA, INC. (ALBO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Duncan has been a net seller of ALBO stock. They have purchased $0 and sold $1.0M worth of shares.
Jason Duncan's most recent insider trade was on Jan 8, 2026, when they sold 750,000 shares at $0.00 per share.
Jason Duncan serves as Executive at ALBIREO PHARMA, INC. (ALBO). They have executed 44 insider transactions totaling $1.0M over their tenure at the company.
Jason Duncan holds the position of Executive at ALBIREO PHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Jason Duncan has shown a selling trading pattern, with $0 in total purchases and $1.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jason Duncan was on Jun 24, 2021, when they sold $363.8K worth of ALBO shares. This transaction involved 10,000 shares at $36.38 per share.
Jason Duncan currently owns 750,000 shares of ALBIREO PHARMA, INC. (ALBO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jason Duncan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jason Duncan has 44 Form 4 filings on record as an insider at ALBIREO PHARMA, INC..
Set alerts for Jason Duncan and 40,000+ other insiders.